Literature DB >> 8916729

Drug trials in epilepsy.

G Mignot.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8916729      PMCID: PMC2352510          DOI: 10.1136/bmj.313.7066.1158

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  4 in total

Review 1.  Medical assessment and treatment of chronic epilepsy.

Authors:  S D Shorvon
Journal:  BMJ       Date:  1991-02-16

2.  New antiepileptic drugs: a systematic review of their efficacy and tolerability.

Authors:  A G Marson; Z A Kadir; D W Chadwick
Journal:  BMJ       Date:  1996-11-09

3.  Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome.

Authors:  M C Walker; L M Li; J W Sander
Journal:  BMJ       Date:  1996-11-09

4.  Measuring antiepileptic therapies: the patient vs the physician viewpoint.

Authors:  D Chadwick
Journal:  Neurology       Date:  1994-11       Impact factor: 9.910

  4 in total
  4 in total

1.  The SF-36 as a health status measure for epilepsy: a psychometric assessment.

Authors:  A Jacoby; G A Baker; N Steen; D Buck
Journal:  Qual Life Res       Date:  1999-06       Impact factor: 4.147

2.  The need for pharmacoeconomic evaluations in the NHS.

Authors:  J P Griffin
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

3.  Newly licensed drugs.

Authors:  R E Ferner
Journal:  BMJ       Date:  1996-11-09

4.  Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic.

Authors:  M W Kellett; D F Smith; P A Stockton; D W Chadwick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-06       Impact factor: 10.154

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.